Analyses of Cryogenic Propellant Tank Pressurization based upon Experiments and Numerical Simulations
The active-pressurization of cryogenic propellant tanks for the launcher application was analyzed in this study. Therefore, ground experiments, numerical simulations and analytical studies were performed with the following important results: In order to minimize the required pressurant gas mass, a higher pressurant gas temperature is advantageous or the application of helium as pressurant gas. Numerical simulations of the pressurant gas mass using Flow-3D show good agreement to the experimental results. The dominating heat transfer during pressurization appears from the injected pressurant gas to the axial tank walls and the predominant way of phase change during the active-pressurization phase depends on the type of the pressurant gas. After the end of the pressurization phase, a significant pressure drop occurs. A theoretical model is presented for the analytical determination of this pressure drop.
Pressurization and expulsion of a flightweight liquid hydrogen tank
Experimental results are presented for pressurization and expulsion of a flightweight 4.89 cu m liquid hydrogen storage tank under normal gravity conditions. Pressurization and expulsion times were parametrically varied to study the effects of longer transfer times expected in future space flight applications. It was found that the increase in pressurant consumption with increased operational time is significant at shorter pressurization or expulsion durations and diminishes as the duration lengthens. Gas-to-wall heat transfer in the ullage was the dominant mode of energy exchange, with more than 50 percent of the pressurant energy being lost to tank wall heating in expulsions and the long duration pressurizations. Advanced data analysis will require a multidimensional approach combined with improved measurement capabilities of liquid-vapor interfacial transport phenomena.
Stereoselective interaction between the R enantiomer of warfarin and cimetidine.
The stereoselectivity of the pharmacokinetic interaction between warfarin and cimetidine was investigated in eight healthy volunteers. The warfarin enantiomers were given separately as single doses (15 mg) alone and during chronic administration of cimetidine (1 g day-1). Cimetidine did not interact with S warfarin but there was an interaction with the R enantiomer of warfarin. Cimetidine caused a significant increase in the mean plasma half-life of R warfarin (from 47.8 h to 57.8 h) and a significant decrease in its mean plasma clearance (from 2.3 to 1.7 ml h-1 kg-1) (P less than 0.02). Administration of a pharmacological dose of vitamin K1 together with the enantiomers of warfarin was necessary clinically and resulted in elevation of vitamin K1 2,3-epoxide concentrations, which were similar in each case.